Enarodustat

恩那度司他

Report date: 2026/02/23 20:01:44
NME

Base Information

Drug NameEnarodustat
Drug Alias Name依那度他恩那司他EnaroyエナロイJTZ-951 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic
Global Approved IndicationsAnemiaRenal Insufficiency, Chronic
Approved Indications in ChinaAnemiaRenal Insufficiency, Chronic
Original Approved Country/TerritoryJapan
Original Approved Date2020/09/25
Country/TerritoryUnited StatesSouth KoreaMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJapan Tobacco (Hong Kong) LtdShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesJw Pharmaceutical CorpAkros Pharma Inc
Active IndicationsAnemiaRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeB03A
Related LinksDrugBankKEGG